Retinoic acid treatment of human neuroblastoma cells is associated with decreased N-myc expression

Biochem Biophys Res Commun. 1985 Feb 15;126(3):1189-95. doi: 10.1016/0006-291x(85)90311-0.

Abstract

Cells from human neuroectodermal tumors (retinoblastoma and neuroblastoma) and from neuroblastoma cell lines express a gene, N-myc, which is frequently amplified in these tumors. We report here that N-myc mRNA content is markedly decreased in cells of a neuroblastoma cell line (LA-N-5) following differentiation induced with retinoic acid. Exposure of the cells to retinoic acid induced morphologic changes consistent with neuronal differentiation, and led to a 75% decrease in expression of N-myc mRNA. These results suggest that N-myc expression is intimately related to an undifferentiated phenotype in neuroblastoma cells, and support other studies which relate N-myc expression to the malignant phenotype in neuroblastoma tumors.

Publication types

  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Cell Differentiation / drug effects
  • Cell Line
  • Gene Expression Regulation / drug effects
  • Humans
  • Neuroblastoma / genetics
  • Neuroblastoma / pathology*
  • Oncogenes / drug effects*
  • RNA, Messenger / metabolism
  • RNA, Neoplasm / metabolism
  • Tretinoin / pharmacology*

Substances

  • RNA, Messenger
  • RNA, Neoplasm
  • Tretinoin